Terms: = Gastric cancer AND SET, I2PP2A, 6418, ENSG00000119335, TAF-IBETA, PHAPII, IGAAD, 2PP2A AND Treatment
527 results:
1. Low prognostic nutrition index as a prognostic biomarker in elderly patients with early gastric cancer after gastrectomy.
Takahashi T; Kaneoka Y; Maeda A; Takayama Y; Aoyama H; Hosoi T; Seita K
J Med Invest; 2024; 71(1.2):113-120. PubMed ID: 38735706
[TBL] [Abstract] [Full Text] [Related]
2. Transfer RNA-derived fragment tRF-23-Q99P9P9NDD promotes progression of gastric cancer by targeting
Zhang Y; Gu X; Li Y; Li X; Huang Y; Ju S
J Zhejiang Univ Sci B; 2024 May; 25(5):438-450. PubMed ID: 38725342
[TBL] [Abstract] [Full Text] [Related]
3. Predicting Helicobacter pylori infection from endoscopic features.
Seo JY; Ahn JY; Kim S; Na HK; Lee JH; Jung KW; Kim DH; Choi KD; Song HJ; Lee GH; Jung HY
Korean J Intern Med; 2024 May; 39(3):439-447. PubMed ID: 38715232
[TBL] [Abstract] [Full Text] [Related]
4. New genetic insights into immunotherapy outcomes in gastric cancer via single-cell RNA sequencing and random forest model.
Yu D; Yang J; Wang B; Li Z; Wang K; Li J; Zhu C
Cancer Immunol Immunother; 2024 May; 73(6):112. PubMed ID: 38693422
[TBL] [Abstract] [Full Text] [Related]
5. The Clinical Impact of the Prognostic Immune and Nutritional Index in gastric cancer Patients Who Received Curative treatment.
Aoyama T; Hashimoto I; Maezawa Y; Hara K; Tamagawa A; Cho H; Morita J; Tanabe M; Numata M; Kawahara S; Oshima T; Saito A; Yukawa N
Anticancer Res; 2024 May; 44(5):2231-2238. PubMed ID: 38677750
[TBL] [Abstract] [Full Text] [Related]
6. Online tools to predict individualised survival for primary oesophageal cancer patients with and without pathological complete response after neoadjuvant therapy followed by oesophagectomy: development and external validation of two independent nomograms.
Cao Y; Huang B; Tang H; Dong D; Shen T; Chen X; Feng X; Zhang J; Shi L; Li C; Jiao H; Tan L; Zhang J; Li H; Zhang Y
BMJ Open Gastroenterol; 2024 Mar; 11(1):. PubMed ID: 38538088
[TBL] [Abstract] [Full Text] [Related]
7. First-line camrelizumab (a PD-1 inhibitor) plus apatinib (an VEGFR-2 inhibitor) and chemotherapy for advanced gastric cancer (SPACE): a phase 1 study.
Chen X; Xu H; Chen X; Xu T; Tian Y; Wang D; Guo F; Wang K; Jin G; Li X; Wang R; Li F; Ding Y; Tang J; Fang Y; Zhao J; Liu L; Ma L; Meng L; Hou Z; Zheng R; Liu Y; Guan N; Zhang B; Tong S; Chen S; Li X; Shu Y
Signal Transduct Target Ther; 2024 Mar; 9(1):73. PubMed ID: 38528050
[TBL] [Abstract] [Full Text] [Related]
8. Construction of a gene model related to the prognosis of patients with gastric cancer receiving immunotherapy and exploration of COX7A1 gene function.
Wang SY; Wang YX; Shen A; Yang XQ; Liang CC; Huang RJ; Jian R; An N; Xiao YL; Wang LS; Zhao Y; Lin C; Wang CP; Yuan ZP; Yuan SQ
Eur J Med Res; 2024 Mar; 29(1):180. PubMed ID: 38494472
[TBL] [Abstract] [Full Text] [Related]
9. A predictive model for intraabdominal infection after radical gastrectomy in elderly patients.
Yu X; Tang W; Bai C; Li R; Feng B; Wu J; Guo X; Chen H; Li M
Medicine (Baltimore); 2024 Mar; 103(11):e37489. PubMed ID: 38489739
[TBL] [Abstract] [Full Text] [Related]
10. Machine learning-based cell death signature for predicting the prognosis and immunotherapy benefit in stomach adenocarcinoma.
Li F; Feng Q; Tao R
Medicine (Baltimore); 2024 Mar; 103(10):e37314. PubMed ID: 38457593
[TBL] [Abstract] [Full Text] [Related]
11. Perioperative or neoadjuvant chemotherapy for locally advanced gastric or gastroesophageal junction cancer: from independent evidence in the West, the East, and Japan to global collaboration.
Nakayama I; Ohashi M; Nunobe S
Chin Clin Oncol; 2024 Feb; 13(1):8. PubMed ID: 38453658
[TBL] [Abstract] [Full Text] [Related]
12. Risk factors, prognostic factors, and nomograms for distant metastases in patients with gastroenteropancreatic neuroendocrine tumors: a population-based study.
Li X; Fan Y; Tong J; Lou M
Front Endocrinol (Lausanne); 2024; 15():1264952. PubMed ID: 38449852
[TBL] [Abstract] [Full Text] [Related]
13. Expression patterns of E2Fs identify tumor microenvironment features in human gastric cancer.
Li F; Yan J; Leng J; Yu T; Zhou H; Liu C; Huang W; Sun Q; Zhao W
PeerJ; 2024; 12():e16911. PubMed ID: 38371373
[TBL] [Abstract] [Full Text] [Related]
14. TRANSCRIPTOME ANALYSIS REVEALED THE MOLECULAR SIGNATURES OF CISPLATIN-FLUOROURACIL COMBINED CHEMOTHERAPY RESISTANCE IN gastric cancer.
Luo Y; Chen X; Hu E; Wang L; Yang Y; Jiang X; Zheng K; Wang L; Li J; Xu Y; Wang Y; Xie Y
Georgian Med News; 2023 Dec; (345):6-18. PubMed ID: 38325291
[TBL] [Abstract] [Full Text] [Related]
15. A ubiquitination-related risk model for predicting the prognosis and immunotherapy response of gastric adenocarcinoma patients.
Shao S; Sun Y; Zhao D; Tian Y; Yang Y; Luo N
PeerJ; 2024; 12():e16868. PubMed ID: 38313020
[TBL] [Abstract] [Full Text] [Related]
16. The macrophage-associated prognostic gene ANXA5 promotes immunotherapy resistance in gastric cancer through angiogenesis.
Hong Z; Wen P; Wang K; Wei X; Xie W; Rao S; Chen X; Hou J; Zhuo H
BMC Cancer; 2024 Jan; 24(1):141. PubMed ID: 38287304
[TBL] [Abstract] [Full Text] [Related]
17. Development and validation of nomogram for predicting early recurrence after radical gastrectomy of gastric cancer.
Cao M; Hu C; Pan S; Zhang Y; Yu P; Zhang R; Cheng X; Xu Z
World J Surg Oncol; 2024 Jan; 22(1):21. PubMed ID: 38243254
[TBL] [Abstract] [Full Text] [Related]
18. A nomogram incorporating treatment data for predicting overall survival in gastroenteropancreatic neuroendocrine tumors: a population-based cohort study.
Wu Z; Shang G; Zhang K; Wang W; Fan M; Lin R
Int J Surg; 2024 Apr; 110(4):2178-2186. PubMed ID: 38241384
[TBL] [Abstract] [Full Text] [Related]
19. Prediction Model of Ocular Metastases in gastric Adenocarcinoma: Machine Learning-Based Development and Interpretation Study.
Zou J; Shen YK; Wu SN; Wei H; Li QJ; Xu SH; Ling Q; Kang M; Liu ZL; Huang H; Chen X; Wang YX; Liao XL; Tan G; Shao Y
Technol Cancer Res Treat; 2024; 23():15330338231219352. PubMed ID: 38233736
[No Abstract] [Full Text] [Related]
20. Phase II study of S-1 plus docetaxel as first-line treatment for older patients with advanced gastric cancer (OGSG 0902).
Kawase T; Imamura H; Kawabata R; Matsuyama J; Nishikawa K; Yanagihara K; Yamamoto K; Hoki N; Kawada J; Kawakami H; Sakai D; Kurokawa Y; Shimokawa T; Satoh T
Int J Clin Oncol; 2024 Feb; 29(2):134-141. PubMed ID: 38227090
[TBL] [Abstract] [Full Text] [Related]
[Next]
